New Vernon Capital Holdings Ii LLC Vir Biotechnology, Inc. Transaction History

New Vernon Capital Holdings Ii LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$22.26 - $30.85 $1,469 - $2,036	66 Added 0.68%	9,702 $225,000
Q4 2022 Feb 14, 2023	BUY	$19.96 - $28.22 $31,057 - $43,910	1,556 Added 19.26%	9,636 $243,000
Q3 2022 Nov 14, 2022	SELL	$18.26 - $31.1 $117,247 - $199,693	-6,421 Reduced 44.28%	8,080 $156,000
Q2 2022 Aug 15, 2022	BUY	$19.08 - $26.7 $276,679 - $387,176	14,501 New	14,501 $369,000

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $991M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of New Vernon Capital Holdings Ii LLC, based on Form 13F filings with the SEC.

Stay updated on New Vernon Capital Holdings Ii LLC with notifications on news.